In Vivo

Show me the money

Show me the money

Drug companies pay MCO's too much in rebates and get too little in return—but "fair share" analysis can help, for some drugs, drive as much as $100 million in additional revenues.

글 Anil Shrivastava, David Bellaire and Ashish Singh

  • 읽기 소요시간

Article

Show me the money
en

Drug companies pay MCO's too much in rebates and get too little in return—but "fair share" analysis can help, for some drugs, drive as much as $100 million in additional revenues.

Download the Full Report (pdf)
태그

프로젝트 사례

A Medical Imaging Company’s CX Overhaul Boosts Customer Satisfaction and Revenue

See more related case studies

전략 A healthcare payer sets its own long-term health strategy

See more related case studies

조직 A Regional Operating Model Lifts European Sales for a Medical Device Maker

See more related case studies

베인에 궁금하신 점이 있으신가요?

베인은 주저 없이 변화를 마주할 줄 아는 용감한 리더들과 함께합니다. 그리고, 이들의 담대한 용기는 고객사의 성공으로 이어집니다.

문의하기

무엇을 도와드릴까요?

오피스 전체보기